ロード中...
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is considered a critical hepatic manifestation of metabolic syndrome. Berberine (BBR) exerts anti-hyperglycemic and anti-dyslipidemic effects and can also ameliorate NAFLD. Thus, BBR might exert its therapeutic effect on NAFLD by improving glucoli...
保存先:
| 出版年: | BMC Endocr Disord |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5329945/ https://ncbi.nlm.nih.gov/pubmed/28241817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-017-0165-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|